Why Perspecta Inc. (NYSE:PRSP) Could Be Worth Watching
While Perspecta Inc. (NYSE:PRSP) might not be the most widely known stock at the moment, it led the NYSE gainers with a relatively large price hike in the past couple of weeks. As a mid-cap stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. However, could the stock still be trading at a relatively cheap price? Let’s take a look at Perspecta’s outlook and value based on the most recent financial data to see if the opportunity still exists.
View our latest analysis for Perspecta
What's the opportunity in Perspecta?
Good news, investors! Perspecta is still a bargain right now. According to my valuation, the intrinsic value for the stock is $44.33, but it is currently trading at US$29.10 on the share market, meaning that there is still an opportunity to buy now. What’s more interesting is that, Perspecta’s share price is quite volatile, which gives us more chances to buy since the share price could sink lower (or rise higher) in the future. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.
Can we expect growth from Perspecta?
Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. However, with an expected decline of -3.5% in revenues over the next couple of years, near-term growth certainly doesn’t appear to be a driver for a buy decision for Perspecta. This certainty tips the risk-return scale towards higher risk.
What this means for you:
Are you a shareholder? Although PRSP is currently undervalued, the adverse prospect of negative growth brings about some degree of risk. I recommend you think about whether you want to increase your portfolio exposure to PRSP, or whether diversifying into another stock may be a better move for your total risk and return.
Are you a potential investor? If you’ve been keeping an eye on PRSP for a while, but hesitant on making the leap, I recommend you research further into the stock. Given its current undervaluation, now is a great time to make a decision. But keep in mind the risks that come with negative growth prospects in the future.
It can be quite valuable to consider what analysts expect for Perspecta from their most recent forecasts. At Simply Wall St, we have the analysts estimates which you can view by clicking here.
If you are no longer interested in Perspecta, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
When trading Perspecta or any other investment, use the platform considered by many to be the Professional's Gateway to the Worlds Market, Interactive Brokers. You get the lowest-cost* trading on stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
Market Insights
Weekly Picks

From a “Shark Tank” Snub to an Air Force “Yes”: Why Virtuix at $3.50 May Be the Market’s Most Mispriced AI Story

Mastercard: The Best Dividend Stock You're Ignoring

A Wonderful Business at a Not-So-Wonderful Price

The Asymmetric TechBio Play: MindWalk Holdings and the Valuation Disconnect
Recently Updated Narratives

CAR Group. A wonderful compounding franchise at a fair-not-cheap price.
Palantir hits 52 week low.
EWY:US NYSE Arca iShares Msci South Korea ETF, an opportunity to diversify your tech investments.
Popular Narratives

Adobe: A Probabilistic Case for Undervaluation

Investment Analysis (May 2026)
